The quadruple regimen including Nexium and furazolidone on a choice to treat helicobacter pylori eradication failure

WANG Jingtong,LIU Yulan

DOI: https://doi.org/10.3969/j.issn.1006-5709.2006.05.021

2006-01-01

Abstract:Objective To investigate the efficacy of Nexium_and_furazolidone-based quadruple therapy to eradicate helicobacter pylori after first_line or second_line treatment failure.Methods Patients with helicobacter pylori infection confirmed by rapid urease test and pathological exam received first-line or second-line international therapy were enrolled. The initial treatment failed if ~ 13 C breath test was positive 4 weeks later. Then such patients received Nexium_and_furazolidone_based quadruple therapy. ~ 13 C breath test was used again to see whetherthe eradication of helicobacter pylori was finally achieved or not. Results Twenty_two patients with initial treatment failure were included in our study and 19 patients achieved eradication of heicobacter pylori after one_week Nexium_and_furazolidone_based quadruple therapy. The eradication rate was 86.4% and minor adverse affects including nausea happened in 22.7% of patients. The associated symptoms disappeared after the quadruple therapy. The medical fee was low as well.Conclusion Nexium_and_furazolidone_based quadruple therapy is an effective, safe, economical choice after first_line or second-line international treatment failure for helicobacter pylori infection.